Literature DB >> 8307060

Staging of Alzheimer-related cortical destruction.

H Braak1, E Braak, J Bohl.   

Abstract

The gradual intraneuronal accumulation of an insoluble fibrous material which partly consists of abnormally phosphorylated tau protein (neurofibrillary change) represents an important neuropathological hallmark of Alzheimer's disease. Neurofibrillary tangles and neuropil threads formed from this material develop in only a few types of cortical pyramidal cells. The first changes are seen in the entorhinal cortex. The destructive process then spreads into the hippocampal formation and eventually encroaches upon the isocortex. This sequence of events permits the distinction of six stages with a progressive increase in the severity of cortical destruction. The entorhinal region serves as an important interface between the isocortex and hippocampus. This interface function is markedly impaired due to the early deterioration of the entorhinal cortex. Severe entorhinal involvement is considered to represent the morphological counterpart of clinically incipient Alzheimer's disease. Similar changes are found in mentally impaired individuals suffering from Parkinson's disease or progressive supranuclear palsy.

Entities:  

Mesh:

Year:  1993        PMID: 8307060     DOI: 10.1159/000116984

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  237 in total

1.  A sparse structure learning algorithm for Gaussian Bayesian Network identification from high-dimensional data.

Authors:  Shuai Huang; Jing Li; Jieping Ye; Adam Fleisher; Kewei Chen; Teresa Wu; Eric Reiman
Journal:  IEEE Trans Pattern Anal Mach Intell       Date:  2013-06       Impact factor: 6.226

2.  Sensory evoked and event related oscillations in Alzheimer's disease: a short review.

Authors:  Görsev G Yener; Erol Başar
Journal:  Cogn Neurodyn       Date:  2010-10-21       Impact factor: 5.082

3.  Mapping the structural brain changes in Alzheimer's disease: the independent contribution of two imaging modalities.

Authors:  Elisa Canu; Donald G McLaren; Michele E Fitzgerald; Barbara B Bendlin; Giada Zoccatelli; Franco Alessandrini; Francesca B Pizzini; Giuseppe K Ricciardi; Alberto Beltramello; Sterling C Johnson; Giovanni B Frisoni
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 4.  The cognitive neuroscience of ageing.

Authors:  Cheryl Grady
Journal:  Nat Rev Neurosci       Date:  2012-06-20       Impact factor: 34.870

5.  Microglial receptor for advanced glycation end product-dependent signal pathway drives beta-amyloid-induced synaptic depression and long-term depression impairment in entorhinal cortex.

Authors:  Nicola Origlia; Camilla Bonadonna; Alfredo Rosellini; Elena Leznik; Ottavio Arancio; Shirley Shidu Yan; Luciano Domenici
Journal:  J Neurosci       Date:  2010-08-25       Impact factor: 6.167

6.  Beta amyloid, tau, neuroimaging, and cognition: sequence modeling of biomarkers for Alzheimer's Disease.

Authors:  S Duke Han; Jonathan Gruhl; Laurel Beckett; Hiroko H Dodge; Nikki H Stricker; Sarah Farias; Dan Mungas
Journal:  Brain Imaging Behav       Date:  2012-12       Impact factor: 3.978

Review 7.  Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections.

Authors:  Wojciech Danysz; Chris G Parsons
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

8.  Longitudinal volumetric MRI change and rate of cognitive decline.

Authors:  D Mungas; D Harvey; B R Reed; W J Jagust; C DeCarli; L Beckett; W J Mack; J H Kramer; M W Weiner; N Schuff; H C Chui
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

9.  Prediction of Alzheimer's disease in subjects with mild cognitive impairment from the ADNI cohort using patterns of cortical thinning.

Authors:  Simon F Eskildsen; Pierrick Coupé; Daniel García-Lorenzo; Vladimir Fonov; Jens C Pruessner; D Louis Collins
Journal:  Neuroimage       Date:  2012-10-02       Impact factor: 6.556

10.  The fornix provides multiple biomarkers to characterize circuit disruption in a mouse model of Alzheimer's disease.

Authors:  Alexandra Badea; Lauren Kane; Robert J Anderson; Yi Qi; Mark Foster; Gary P Cofer; Neil Medvitz; Anne F Buckley; Andreas K Badea; William C Wetsel; Carol A Colton
Journal:  Neuroimage       Date:  2016-08-10       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.